According to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification, levels of vWF increase in all types of stroke in its acute phase, although after 3 months its increased concentration remains in the cardioembolic and cryptogenic stroke [107]. This evidence concerns the gene VWF and stroke disorder.